Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (20000)	5/4/1998 9:51:00 AM
From: Hippieslayer	Read Replies (1) \| Respond to of 32384

Lgnd is moving in anti sympathy with enmd. down an eigths!

To: Henry Niman who wrote (20000)	5/4/1998 12:29:00 PM
From: Machaon	Read Replies (7) \| Respond to of 32384

<< Although LGND didn't get to $20 before the 20,000th posts >> I think that Walter was actually predicting that ENMD would hit $20 before LGND's 20,000 post. ENMD's price soars up $70 on mice cancer tests. I wonder what would've happened to LGND's stock price if their mice tests had been hyped better? I know what it is! It's LGND's tests on naked mice that did it. Sad to say, the public might'of been turned off by the image of male and female naked meeses frolicking around in their cages! I wonder if this ENMD stock action will draw more money into the biotech sector? With most other sectors selling at premiums, and with the possibility of a biotech going from $12 to $80 in one hour, could it bode well for the bios? Regards, Bob